Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol IVF
- Company NAYA Biosciences, Inc. Common Stock
- Price $0.58
- Changes Percentage -10.46
- Change -0.07
- Day Low $0.58
- Day High $0.67
- Year High $37.44
- Year Low $0.5
- Market Cap $536,634
- Price Avg 50 EMA (D) $0.91
- Price Avg 200 EMA (D) $5.98
- Exchange NASDAQ
- Volume 2,653,534
- Average Volume 4,881,028
- Open $0.63
- Previous Close $0.65
- EPS -92.72
- PE -0.01
- Earnings Announcement 2025-08-12 10:59:00
- Shares Outstanding $928,272
Company brief: NAYA BIOSCIENCES, INC. COMMON STOCK (IVF )
- Healthcare
- Medical - Healthcare Plans
- https://www.invobio.com
- US
- N/A
- 01-14-2025
INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc., is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care. The company focuses on building, acquiring, and operating fertility clinics, including “INVO Centers” offering the intravaginal culture (IVC) procedure enabled by its proprietary INVOcell® medical device. This device allows fertilization and early embryo development to occur in vivo within the woman’s body, providing a more natural, intimate, and affordable alternative to traditional IVF. INVO Fertility operates multiple centers in the U.S. and distributes the INVOcell technology to third-party clinics. The company separated its fertility and oncology businesses in April 2025 to focus exclusively on fertility care.
